Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 5 sources · 16 days · First seen about 1 month ago · Last updated 19 days ago

New Amsterdam Invest financial performance

Overview

New Amsterdam Invest reported growth in revenue and profit for the first half of 2026. The company’s operating profit increased by 1.33 million euros to 4.47 million euros, with net profit reaching 1.1 million euros.

CEO Aren van Dam indicated expectations for continued growth through the expansion of the company’s real estate portfolio, aiming to maintain its status as a dividend-paying stock. For the full fiscal year, the company projects an operating profit of approximately 10 million euros and net rental income of approximately 13 million euros.

Entities

Royal Bank of Canada · Jefferies Financial Group · NewAmsterdam Pharma Company N. V. · BMO Capital Markets · HC Wainwright

Timeline

19 days ago

[BUSINESS] 5 sources
New Amsterdam Invest reports growth in H1 2026
New Amsterdam Invest reported increased revenue and profit for the first half of 2026, driven by real estate portfolio expansion, and expects continued growth throughout the year.
about 1 month ago

[BUSINESS] 4 sources
NewAmsterdam Pharma faces lowered earnings estimates after Investor Day
NewAmsterdam Pharma held its annual Investor Day amid shifting analyst expectations, including a lowered Q3 2026 EPS estimate from HC Wainwright.

Sources

cashcow.nl · negocios.com · tabsholland.nl · theasset.nl · wijzuidholland.nl